Abstract
Studies of infants identified by newborn screening for cystic fibrosis have shown that the pulmonary diseases start early, prior to the development of clinical symptoms. In this issue of The Journal, Stick et al from the Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF) have studied bronchiectasis in young children with cystic fibrosis diagnosed by newborn screening. They found a prevalence of 22% which increased with age, so current treatment of infants with cystic fibrosis does not always prevent the development of permanent pulmonary sequalae.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
